XUE, ELISABETTA
 Distribuzione geografica
Continente #
NA - Nord America 208
EU - Europa 148
AS - Asia 44
OC - Oceania 1
Totale 401
Nazione #
US - Stati Uniti d'America 207
IT - Italia 86
SE - Svezia 54
CN - Cina 24
SG - Singapore 10
IN - India 7
DE - Germania 3
FI - Finlandia 3
HK - Hong Kong 3
AU - Australia 1
ES - Italia 1
IE - Irlanda 1
MX - Messico 1
Totale 401
Città #
Milan 32
New York 31
Ashburn 29
Shanghai 19
Chandler 9
Lawrence 9
Princeton 9
Rome 9
Boardman 7
Pune 7
Singapore 6
Seattle 4
Bologna 3
Brescia 3
Genoa 3
Pisa 3
Avellino 2
Borgomanero 2
Carpenedolo 2
Castelseprio 2
Chaoyang 2
Helsinki 2
Hong Kong 2
Ome 2
Santa Clara 2
Verona 2
Washington 2
Cormano 1
Dublin 1
Elmendorf 1
Lappeenranta 1
Logroño 1
Los Angeles 1
Macerata 1
Mexico City 1
Newark 1
Sydney 1
Totale 215
Nome #
Case report: Ponatinib as a bridge to CAR-T cells and subsequent maintenance in a patient with relapsed/refractory Philadelphia-like acute lymphoblastic leukemia 38
Allogeneic hematopoietic stem cell transplantation in patients older than 65 years with acute myeloid leukemia and myelodysplastic syndrome: a 15-year experience 28
Levofloxacin prophylaxis vs no prophylaxis in neutropenic patients within an endemic country for carbapenem-resistant GNB 24
Interleukin-6 as Biomarker for Acute GvHD and Survival After Allogeneic Transplant With Post-transplant Cyclophosphamide 24
Quantitative polymerase chain reaction-based chimerism in bone marrow or peripheral blood to predict acute myeloid leukemia relapse in high-risk patients: results from the KIM-PB prospective study 24
Addition of a Single Low Dose of Anti T-Lymphocyte Globulin to Post-Transplant Cyclophosphamide after Allogeneic Hematopoietic Stem Cell Transplant: A Pilot Study 23
COVID-19 in recipients of allogeneic stem cell transplantation: favorable outcome 23
Letermovir reduces chronic GVHD risk in calcineurin inhibitor-free GVHD prophylaxis after hematopoietic cell transplantation 21
Treosulfan-Based Conditioning Regimen Prior to Allogeneic Stem Cell Transplantation: Long-Term Results From a Phase 2 Clinical Trial 21
Posttransplantation Cyclophosphamide- and Sirolimus-Based Graft-Versus-Host-Disease Prophylaxis in Allogeneic Stem Cell Transplant 21
Dynamics of polyclonal immuno-reconstitution after allogeneic transplant with post-transplant cyclophosphamide and letermovir 18
Coadministration of letermovir and sirolimus in allogeneic hematopoietic cell transplant recipients 17
Defibrotide Prophylaxis of Sinusoidal Obstruction Syndrome in Adults Treated With Inotuzumab Ozogamicin Prior to Hematopoietic Stem Cell Transplantation 16
Infections after Allogenic Transplant with Post-Transplant Cyclophosphamide: Impact of Donor HLA Matching 16
Case Report: Favorable outcome of allogeneic hematopoietic stem cell transplantation in SARSCoV2 positive recipient, risk-benefit balance between infection and leukemia 15
Longitudinal qPCR monitoring of nucleophosmin 1 mutations after allogeneic hematopoietic stem cell transplantation to predict AML relapse 15
Splenic irradiation prior to allogeneic transplant conditioning in myelofibrosis: A pilot experience 14
Cytomegalovirus-specific T cells restricted for shared and donor human leukocyte antigens differentially impact on Cytomegalovirus reactivation risk after allogeneichematopoietic stem cell transplantation 14
Cellular and transcriptional dynamics of human neutrophils at steady state and upon stress 13
Erratum: Lung ultrasound to evaluate invasive fungal diseases after allogeneic hematopoietic stem cell transplantation (Infection and Chemotherapy (2019) 51: 4 (386-392) DOI: 10.3947/ic.2019.51.4.386) 13
Ruxolitinib for chronic steroid-refractory graft versus host disease: a single center experience 13
Post-transplant cyclophosphamide and sirolimus based graft-versus-host disease prophylaxis after allogeneic stem cell transplantation for acute myeloid leukemia 11
Impact of tixagevimab/cilgavimab prophylaxis in patients undergoing allogeneic hematopoietic stem cell transplants and CAR T-cell therapy: A single center experience 9
Human herpesvirus 6-specific T-cell immunity in allogeneic hematopoietic stem cell transplant recipients 8
Intrabone Transplantation of a Single Unwashed Umbilical Cord Blood Unit with Antithymocyte Globulin-Free and Sirolimus-Based Graft-versus-Host Disease Prophylaxis: Fast Immune Reconstitution and Long-Term Disease Control in Patients with High-Risk Diseases 2
Totale 441
Categoria #
all - tutte 3.977
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 3.977


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20216 0 0 0 2 1 2 1 0 0 0 0 0
2021/202219 0 0 0 4 0 1 0 7 4 0 0 3
2022/2023162 21 16 6 4 23 18 6 19 15 9 17 8
2023/2024248 15 17 32 34 27 52 4 31 0 10 3 23
2024/20256 6 0 0 0 0 0 0 0 0 0 0 0
Totale 441